The flush of cash highlighted Axovant’s then-29-year-old CEO, Vivek Ramaswamy, whose jump from hedge fund analyst to biotech executive attracted headlines and put his net worth in the hundreds of millions. Since that 2015 offering, Ramaswamy spun out other pharmaceutical companies, foundedan ...
Vivek Ramaswamy (born 1985) is an American biotech entrepreneur who drew national attention with his bid for the Republican nomination in the 2024 U.S. presidential election.